genzyme

  1. T

    Genzyme Study Of Myozyme Treatment For Pompe Disease Published In New England Journal

    Genzyme Corp. (NASDAQ: GENZ) today announced that the results from its Late-Onset Treatment Study (LOTS) have been published in today's New England Journal of Medicine. The study was undertaken to evaluate the safety and efficacy of Myozyme (alglucosidase alfa) in older children and adults with...
    • tD33NAt
    • Thread
    • disease england genzyme journal myozyme pompe published study treatment
    • Replies: 0
    • Forum: Health and Fitness
  2. T

    Genzyme Study Of Myozyme Treatment For Pompe Disease Published In New England Journal

    Genzyme Corp. (NASDAQ: GENZ) today announced that the results from its Late-Onset Treatment Study (LOTS) have been published in today's New England Journal of Medicine. The study was undertaken to evaluate the safety and efficacy of Myozyme (alglucosidase alfa) in older children and adults with...
    • tD33NAt
    • Thread
    • disease england genzyme journal myozyme pompe published study treatment
    • Replies: 0
    • Forum: Health and Fitness
  3. T

    Genzyme Study Of Myozyme Treatment For Pompe Disease Published In New England Journal

    Genzyme Corp. (NASDAQ: GENZ) today announced that the results from its Late-Onset Treatment Study (LOTS) have been published in today's New England Journal of Medicine. The study was undertaken to evaluate the safety and efficacy of Myozyme (alglucosidase alfa) in older children and adults with...
    • tD33NAt
    • Thread
    • disease england genzyme journal myozyme pompe published study treatment
    • Replies: 0
    • Forum: Health and Fitness
  4. M

    Patient beware: Contamination found in Genzyme drugs for rare disorders

    [No message]
    • M_Smith
    • Thread
    • beware contamination disorders drugs found genzyme patient rare
    • Replies: 0
    • Forum: Reviews
Back
Top